Medicare: Patients on Medicare may be eligible if: They have spent more than $1,000 on prescription medications under Medicare Part D this calendar year, or They were denied Medicare Extra Help/Low Income Subsidy (LIS) and do not have Medicare Part D coverage
PlexusDx offers both injectable and oral options across its compounded medication line, including semaglutide injection (at $189/mo month-to-month, or from $149/mo on the 6-month plan) and tirzepatide injection (at $289/mo month-to-month, or from $249/mo on the 6-month plan)
The combination can lead to serious over-exfoliation, dry, irritated skin, and can even damage the skin barrier over time
BPC 157 is used for its potential benefits in healing, recovery, and reducing inflammation
Unlike single-action drugs, retatrutide targets multiple receptors in the body, including GLP-1, GIP, and glucagon receptors